As per the report published by Allied Market Research, the global Anti-Inflammatory Therapeutics Market was accounted for $98.02 billion in 2020, and is estimated to hit $125.55 billion by 2028, growing at a CAGR of 4.0% from 2021 to 2028.
Rise in prevalence of autoimmune diseases and chronic respiratory conditions, advent of new drugs, and surge in adoption rate of anti-inflammatory drugs drive the growth of the global anti-inflammatory therapeutics market. However, side effects of anti-inflammatory drugs and patent expiration hinder the market growth. On the contrary, development of biosimilars for existing drugs is expected to open lucrative opportunities for the market players in the future.
Download Sample Report at: https://www.alliedmarketresearch.com/request-sample/286
Inflammation is the body’s natural response to injury or infection. While it’s essential for healing, chronic inflammation can fuel a wide range of diseases — from arthritis and cardiovascular disorders to neurodegenerative conditions and cancer. That’s where anti-inflammatory therapeutics come into play, offering hope for millions of people living with chronic inflammation.
Anti-Inflammatory Therapeutics Market Segmentation
The global anti-inflammatory therapeutics market is segmented into indication, drug class, and region. Depending on indication, the market is categorized into arthritis, respiratory diseases, multiple sclerosis, psoriasis, anti-inflammatory bowel disease (IBD), and other anti-inflammatory diseases. By drug class, it is segregated into nonsteroidal anti-inflammatory drugs (NSAIDs), corticosteroids, and biologics. Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
Based on drug class, the anti-inflammatory biologics segment held the lion’s share in 2020, accounting for nearly three-fifths of the market. Moreover, the segment is expected to register the highest CAGR of 4.3% during the forecast period. The research also analyzes the segments including nonsteroidal anti-inflammatory drugs (NSAIDs) and corticosteroids.
Enquiry for Short-term and Long-term Impacts of COVID-19 at: https://www.alliedmarketresearch.com/purchase-enquiry/286
On the basis of indication, the Psoriasis segment would showcase the highest CAGR of 4.9% during the forecast period. However, the arthritis segment held the largest share in 2020, contributing to around two-fifths of the market.
The global anti-inflammatory therapeutics market is analyzed across several regions such as North America, Europe, Asia-Pacific, and LAMEA. The market across North America dominated in 2020, holding more than one-third of the market. However, the market across Asia-Pacific is expected to manifest the highest CAGR of 5.2% from 2021 to 2028.
The global anti-inflammatory therapeutics market report includes an in-depth analysis of the prime market players such as Abbvie, Inc., Pfizer, Inc., GlaxoSmithKline, Johnson & Johnson, Novartis, Merck & CO., Inc., La Roche AG, F. Hoffman, AstraZeneca PLC, Eli Lily and Company, and Amgen.
Read More:
Nutrigenomics Market is rising at a CAGR of 17.2% from 2023 to 2032 | Allied
Global Radiopharmaceuticals Market Booms with Rising Demand for Targeted Diagnostics
Contact Details:
David Correa
USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022
About Us
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of “Market Research Reports” and “Business Intelligence Solutions.” AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.
